Recent research proposed that the pathway based on the axis GNAQ/11–PLCβ–PKC–MAPK could be a preferential target in the treatment of tumours with underlying Gαq pathway mutations, such as most of the UM cases [65]. Here, GNAQ is linked to neoplasm.